Surgery Godfather

Chapter 1454: Chapter 1082: Going to Raise Pigs with an Organizational Quota Chapter 1454: Chapter 1082: Going to Raise Pigs with an Organizational Quota Cultivating cells was Tang Shun’s forte. He and Li Yingtong were among the world’s top young talents in stem cells, and cultivating NK cells was a piece of cake for them.

The experiment was a sequence of interconnected steps. Recombining genes in K cells was a task for the Nandu Medical University Genetics Laboratory. Once they had completed their part, they sent the NK seed cells over to Sanbo Hospital. Using these seed cells, Tang Shun would carry out cultivation, which is to say, expansion, causing these cells to divide exponentially, splitting from one into two, two into four, four into eight… and so on, until the desired quantity was reached.

With his persuasive eloquence and international experience from his travels abroad, Tang Shun was able to recruit a group of the top talents who had studied overseas. Now nearly every researcher in his laboratory holds a Doctorate from a top European or American university.

It’s not to say that domestic universities are inferior, but they started out later. In terms of foundation research, especially in the field of basic medical biological research, they lag far behind Europe and America. For instance, in pharmaceuticals, we have few original drugs of our own; artemisinin stands out as an exceptional representative. But the vast majority of drugs we encounter are originated in Europe and America, and we are merely replicating followers, sometimes without a full understanding of the drugs we are copying. Some pharmaceutical giants in Europe and America have produced several Nobel Prize winners, which reveals their formidable R&D capabilities. Compared to the R&D power of these pharmaceutical titans, the R&D of our domestic pharmaceutical companies seems rather elementary. Both the willingness and the capability for R&D are incredibly feeble, so in this regard, we have a long way to go. We must recognize the gaps and strive to catch up.

R&D is a systemic engineering feat requiring a solid foundation: talent, capital, management, and culture—all are indispensable. With only talent and capital and no scientific management, funds get wasted and talents cannot perform effectively. Without a culture of innovation, even huge investments in funds and manpower will be mere flashes in the pan, lacking sustainable R&D capabilities. Money will be spent in vain, and eventually, the team will have to be disbanded.

Therefore, building a complete R&D system is of paramount importance. Even with various resources now at Yang Ping’s disposal, establishing a world-class laboratory requires taking one step at a time; success will not come overnight.